Verona Pharma plc buy Wells Fargo & Company
Start price
03.10.24
/
50%
€0.51
Target price
03.10.25
€45.31
Performance (%)
-
End price
04.10.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verona Pharma plc | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma plc (NASDAQ: VRNA) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $50.00 price target on the stock.
Ratings data for VRNA provided by MarketBeat
In the thread Trading Verona Pharma plc
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten